Compugen Stock

Compugen EBITDA Growth YoY

The Year-over-Year EBITDA Growth of Compugen (CGEN) as of Aug 13, 2026 is 310.37 %. In the previous year, Year-over-Year EBITDA Growth was -14.62 % — a change of -2,223.39% (higher).

EBITDA Growth YoY

310.37 %

YoY

-2,223.39%

Last updated:

Year-over-Year EBITDA Growth of Compugen is 2026 310.37 % . Year-over-Year EBITDA Growth of Compugen was 2025 -14.62 % . It decreases by -2,223.39% higher compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Year-over-Year EBITDA Growth of Compugen is 310.37 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year EBITDA Growth Compugen since 2006 – with annual values, charts, and detailed analysis.

EBITDA growth measures the percentage change in EBITDA compared to the prior year. It shows changes in operating cash earnings before capital structure effects.

To evaluate Year-over-Year EBITDA Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBITDA Growth.

Year-over-Year EBITDA Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBITDA Growth's Compugen historically and in real time.

Access this data via the Eulerpool API

Growth — Compugen

All Key Metrics — Compugen